Results for "Dasatinib + Quercetin" in Parkinson's

20 articles

Dasatinib and Quercetin Reach the Brain in Early Alzheimer's Patients
Brain Health

Dasatinib and Quercetin Reach the Brain in Early Alzheimer's Patients

A completed Phase 1/2 pilot trial tested whether the senolytic duo D+Q penetrates the brain in early Alzheimer's disease.

Clinical Trial
May 28, 2026 0
Popular Anti-Aging Drug Combo Dasatinib+Quercetin Causes Brain Damage in Mice
Brain Health

Popular Anti-Aging Drug Combo Dasatinib+Quercetin Causes Brain Damage in Mice

New mouse research finds the trendy D+Q senolytic combo severely damages myelin, raising red flags for longevity self-experimenters.

Press Release
May 28, 2026 0
Fisetin Targets Brain Inflammation in Alzheimer's Through CD44 Protein Pathway
Brain Health

Fisetin Targets Brain Inflammation in Alzheimer's Through CD44 Protein Pathway

Single-cell analysis reveals how the flavonoid fisetin may reduce neuroinflammation in Alzheimer's disease by targeting specific astrocyte subgroups.

Research Paper
Apr 2, 2026 0
Flavonoid Supplement Shows Promise for Cognitive Function in Elderly Adults
Brain Health

Flavonoid Supplement Shows Promise for Cognitive Function in Elderly Adults

Italian researchers test plant-based compounds for brain health and quality of life in aging adults with promising early results.

Clinical Trial
Mar 28, 2026 2
p53-DDIT4-NF-ฮบB Pathway Drives Depression โ€” Curcumin Blocks It
Brain Health

p53-DDIT4-NF-ฮบB Pathway Drives Depression โ€” Curcumin Blocks It

New research maps a stress-signaling cascade linking p53 activation to brain inflammation and depression, with curcumin interrupting it.

Research Paper
May 3, 2026 0
Combination Neuroprotective Compounds Show Promise for Glaucoma Vision Loss
Brain Health

Combination Neuroprotective Compounds Show Promise for Glaucoma Vision Loss

New review reveals how combining citicoline, CoQ10, and other agents may protect retinal cells better than single treatments.

Research Paper
Apr 4, 2026 0
Vitamin B3 Boosts Immune Attack on Glioblastoma in Early Clinical Trial
Brain Health

Vitamin B3 Boosts Immune Attack on Glioblastoma in Early Clinical Trial

High-dose niacin revived suppressed immune cells in glioblastoma patients, with 82% showing no progression at 6 months โ€” 28% better than expected.

Press Release
Jun 23, 2026 0
Drugs That Boost Brain Waste Clearance During Sleep Show Promise Against Alzheimer's
Brain Health

Drugs That Boost Brain Waste Clearance During Sleep Show Promise Against Alzheimer's

A Phase 1/2 trial tests whether dexmedetomidine can enhance the brain's glymphatic system to clear amyloid and tau during sleep.

Clinical Trial
May 16, 2026 0
Statins May Prevent Dementia in People with High Genetic Risk
Brain Health

Statins May Prevent Dementia in People with High Genetic Risk

New research reveals statins could reduce dementia risk by 85% in genetically susceptible individuals, offering personalized prevention.

Research Paper
Mar 29, 2026 3
PQQ Shows Promise for Alzheimer's and Parkinson's Through Multiple Brain Pathways
Brain Health

PQQ Shows Promise for Alzheimer's and Parkinson's Through Multiple Brain Pathways

Review reveals how PQQ supplement protects neurons via antioxidant, mitochondrial, and anti-inflammatory mechanisms in neurodegenerative diseases.

Research Paper
Apr 4, 2026 0
Herbal Compound Clears Alzheimer's Plaques by Activating AMPK Autophagy Pathway
Brain Health

Herbal Compound Clears Alzheimer's Plaques by Activating AMPK Autophagy Pathway

A traditional Chinese herbal formula improves cognition and cerebrovascular health in Alzheimer's mice by activating the LKB1-AMPK-SIRT1 autophagy cascade.

Research Paper
May 21, 2026 0
Adenosine Receptor Blocker Boosts Brain Recovery After Stroke by 40%
Brain Health

Adenosine Receptor Blocker Boosts Brain Recovery After Stroke by 40%

DPCPX treatment enhanced neurogenesis and improved motor/memory function in stroke recovery studies using advanced PET imaging.

Research Paper
Apr 9, 2026 0
Cancer Drug Cytarabine Causes Brain Damage Through DNA Repair Disruption
Brain Health

Cancer Drug Cytarabine Causes Brain Damage Through DNA Repair Disruption

New research reveals why cytarabine chemotherapy causes severe cerebellar toxicity while similar drugs don't.

Research Paper
Apr 16, 2026 0
Metabolic Therapy Prevents Childhood Stroke Disease in Genetic Mouse Model
Brain Health

Metabolic Therapy Prevents Childhood Stroke Disease in Genetic Mouse Model

Nicotinamide riboside prevents moyamoya-like brain vessel blockages by fixing cellular energy production in smooth muscle cells.

Research Paper
Apr 4, 2026 0
Current Drugs for Friedreich Ataxia Show Little Benefit After One Year
Brain Health

Current Drugs for Friedreich Ataxia Show Little Benefit After One Year

A Cochrane meta-analysis of 8 RCTs finds most pharmacological treatments fail to improve ataxia scores, though upper limb dexterity may benefit.

Review
May 13, 2026 0
FDA Approves Four Neurological Drugs Targeting Alzheimer's, Glioma, and Rare Disease
Brain Health

FDA Approves Four Neurological Drugs Targeting Alzheimer's, Glioma, and Rare Disease

A roundup of recent FDA brain-health approvals including lecanemab's full Alzheimer's approval and a new glioma drug.

Drug Approval
May 5, 2026 0
Single vs Double Bevacizumab Injections Compared for Macular Degeneration Treatment
Brain Health

Single vs Double Bevacizumab Injections Compared for Macular Degeneration Treatment

A Phase 4 RCT tests whether one bevacizumab injection matches two combined doses for neovascular AMD outcomes over 12 months.

Clinical Trial
May 8, 2026 0
Exercise Fights Chemo Brain Better Than Ibuprofen in New Clinical Trial
Brain Health

Exercise Fights Chemo Brain Better Than Ibuprofen in New Clinical Trial

A home-based walking and resistance program improved attention and reduced observable cognitive decline in chemotherapy patients over 6 weeks.

Press Release
Jun 11, 2026 0
Arthritis Drug Eases Treatment-Resistant Depression by Calming Inflammation
Brain Health

Arthritis Drug Eases Treatment-Resistant Depression by Calming Inflammation

A small trial found tocilizumab, an anti-inflammatory drug, cut depression remission rates better than SSRIs by targeting IL-6, not brain chemistry.

Press Release
May 28, 2026 0
Diabetes Drug Metformin Shows Promise for Parkinson's Disease Treatment
Brain Health

Diabetes Drug Metformin Shows Promise for Parkinson's Disease Treatment

60-patient trial explores whether metformin, combined with standard therapy, could slow Parkinson's progression through metabolic pathways.

Clinical Trial
Mar 28, 2026 1
Page 1 of 2Next